Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma

StatusUnknown
PhaseNot specified
Started

Record status This record was last updated July 3, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to develop a predictive model using deep learning and radiomics to assess the likelihood of lymph node metastasis in patients with early-stage esophageal squamous cell carcinoma (ESCC). Lymph node metastasis is a critical factor in determining the treatment approach and prognosis for ESCC patients. By analyzing medical imaging data, we hope to create a non-invasive method that can assist doctors in making more accurate treatment decisions. This research could improve patient outcomes by enabling earlier and more tailored interventions.
Trial Details
NCT Number NCT07050576
Lead Sponsor The First Affiliated Hospital of Anhui Medical University
Conditions
(from sponsor)		 ESCC, Lymph Node Metastasis, Radiomics
Related terms Lymphatic Metastasis
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov